Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Lei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1479-3967; OpenAlex author ID A5100440288. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. Exosomal miR-19a decreases insulin production by targeting Neurod1 in pancreatic cancer associated diabetes. Co-author DOI 10.1007/s11033-021-06980-z↗
  2. Pancreatic cancer-derived exosomal microRNA-19a induces β-cell dysfunction by targeting ADCY1 and EPAC2. Last author DOI 10.7150/ijbs.56271↗
  3. VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells. First author DOI 10.1136/gutjnl-2018-316627↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenjing Pang · 2 shared papers, 2021–2022 · strength 0.31
  2. Xin Dai · 2 shared papers, 2021–2022 · strength 0.31
  3. Weiyan Yao · 2 shared papers, 2021–2022 · strength 0.31
  4. Jiaojiao Su · 1 shared paper, 2022 · strength 0.19
  5. Xiangjun Meng · 1 shared paper, 2021 · strength 0.13
  6. Xiangyu Kong · 1 shared paper, 2019 · strength 0.11
  7. Zhaoshen Li · 1 shared paper, 2019 · strength 0.11
  8. Fanyang Kong · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.